Answers are grounded in this paper and cite their sources.
The in vitro activity of gemifloxacin against 316 bloodstream isolates of staphylococci, pneumococci, and enterococci was compared with the activities of six fluoroquinolones and three other antimicrobial agents. Of the antimicrobial agents tested, gemifloxacin was the most potent against penicillin-intermediate and -resistant pneumococci, methicillin-susceptible and -resistant Staphylococcus epidermidis isolates, and coagulase-negative staphylococci.
No takes yet. Share an insight, caveat, or question.
Hardy et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: